Text Size

Study of Value of Cardiac PET Scans With or Without CT Angiography and/or Measurement of Coronary Flow Reserve

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Kettering Health Network
ClinicalTrials.gov Identifier:
NCT00669968
First received: April 29, 2008
Last updated: May 30, 2012
Last verified: May 2012
History of Changes
  Purpose

How does PET myocardial perfusion imaging involving CT angiography and measurement of coronary flow reserve affect patient care.


Condition
Chest Pain
Coronary Artery Disease

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: PET Myocardial Perfusion Imaging With CT Angiography and Measurement of Coronary Flow Reserve: A Prospective Study of Effectiveness, Impact on Patient Management, Prognostic Value, and Downstream Costs

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Kettering Health Network:

Enrollment: 17
Study Start Date: February 2008
Study Completion Date: May 2011
Primary Completion Date: May 2011 (Final data collection date for primary outcome measure)
Detailed Description:

The purpose of this research is to determine how PET myocardial perfusion imaging involving CT angiography and measurement of coronary flow reserve affects patient care. This research will also compare the effectiveness of these scans to other similar tests and compare the cost-effectiveness of these scans to other similar tests over time.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients who undergo Rubidium PET adenosine stress test with or without CT angiography of coronary arteries and/or coronary flow reserve measurment at Kettering Medical Medical Center.

Criteria

Inclusion Criteria:

  • Patients referred to Kettering Medical Center for PET myocardial perfusion imaging with or without CTA and/or coronary flow reserve measurement.
  • Patients over 18 years of age.

Exclusion Criteria:

  • Patients who do not consent to participate.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00669968

Locations
United States, Ohio
Kettering Medical Center
Kettering, Ohio, United States, 45429
Sponsors and Collaborators
Kettering Health Network
Investigators
Principal Investigator: Nathaniel Dittoe, MD Kettering Health Network
  More Information

No publications provided

Responsible Party: Kettering Health Network
ClinicalTrials.gov Identifier: NCT00669968     History of Changes
Other Study ID Numbers: 07-034
Study First Received: April 29, 2008
Last Updated: May 30, 2012
Health Authority: United States: Institutional Review Board

Keywords provided by Kettering Health Network:
PET myocardial perfusion imaging
Cardiac PET
Rubidium
 Coronary Artery CT Angiogram
Coronary Flow Reserve
Adenosine stress test

Additional relevant MeSH terms:
Chest Pain
Coronary Artery Disease
Myocardial Ischemia
Coronary Disease
Pain
Signs and Symptoms
 Heart Diseases
Cardiovascular Diseases
Arteriosclerosis
Arterial Occlusive Diseases
Vascular Diseases

ClinicalTrials.gov processed this record on May 16, 2013